Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7279
Rank
A$0.79 B
Marketcap
A$22.81
Share price
-0.33%
Change (1 day)
-51.30%
Change (1 year)

Avalon Pharma (Middle East Pharmaceutical) (4016.SR) - Total assets

Total assets on the balance sheet as of March 2026 : A$0.23 Billion

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's total assets are A$0.23 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Avalon Pharma (Middle East Pharmaceutical) - Total assets on balance sheet (from 2023 to 2026)

Total assets by year

Year Total assets Change
2025-12-31A$0.23 B5.8%
2024-12-31A$0.22 B27.22%
2023-12-31A$0.17 B